EUVIMEDEUVIMED entdecken
Crossref

Fluoxetine treatment reverses chronic stress-induced promotion on Fk506-binding protein 5 expression and multiple effects on glucocorticoid receptor phosphorylation in the paraventricular nucleus of mice

Bao-Lun Zhu, Jin-Yan Tang, Wei-Jia Chen, Jun-Jie Qian, Feng Zhang, Xiao-Ling Zhang, Ting-Ting Chen, Bo Jiang, He-Yan Zhao

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2024.173916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Bao-Lun Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China; Department of Clinical Nursing, School of Nursing…. Hauptthemen laut MEDLINE: Fluoxetine, Tacrolimus Binding Proteins, Receptors, Glucocorticoid, Paraventricular Hypothalamic Nucleus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fluoxetine is widely used as a first-line antidepressant. However, the molecular mechanisms for its antidepressant effects are still not fully understood. Hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis is a core pathogenic mechanism contributing to depression, and fluoxetine treatment prevents this dysfunction. The glucocorticoid receptor (GR) is a major negative feedback regulator of the HPA axis, while Fk506-binding protein 5 (Fkbp5) is a negative regulator of the GR signaling. Therefore, we examined the effects of fluoxetine on Fkbp5 and the GR signaling in the hypothalamic paraventricular nucleus (PVN) of depressed mice. METHODS: Mice were exposed to chronic social defeat stress (CSDS), chronic unpredictable mild stress (CUMS), or chronic restraint stress (CRS) with or without fluoxetine treatment (intraperitoneally injected, 20 mg/kg) and examined for changes in depression-like behaviors and HPA axis activity as well as Fkbp5 expression and GR phosphorylation in the PVN. We then examined if adeno-associated virus (AAV)-mediated Fkbp5 overexpression in the PVN affected the antidepressant actions of fluoxetine in mice. RESULTS: Fluoxetine treatment significantly mitigated CSDS-, CUMS-, and CRS-induced depression-like behaviors and HPA axis hyperactivity in mice. Subsequent western blotting analyses showed that fluoxetine treatment fully reversed not only chronic stress-induced upregulation of Fkbp5 and CRH but also chronic stress-induced increase in Ser203 phosphorylation and decrease in Ser211 and Ser234 phosphorylation in GR in the PVN. Moreover, quantitative real-time reverse transcription PCR (qRT-PCR) analyses revealed that the enhanced mRNA levels of Fkbp5 and CRH in PVN neurons of mice subjected to CSDS/CUMS/CRS were also notably reversed by fluoxetine administration. Conversely, Fkbp5 overexpression in the PVN significantly eliminated the antidepressant effects of fluoxetine in mice without affecting their locomotor activity. CONCLUSION: These results together suggest that fluoxetine treatment reverses chronic stress-induced promotion on Fkbp5 expression and multiple effects on GR phosphorylation in the PVN of mice. SIGNIFICANCE STATEMENT: The selective serotonin reuptake inhibitor fluoxetine (sold as Prozac) is a widely used treatment for depression, but the full spectrum of therapeutic mechanisms is still debated. Recent evidence suggests that these therapeutic mechanisms include suppression of chronic stress-activated hypothalamus-pituitary-adrenal (HPA) axis. The current study presents the first in vivo evidence showing that suppression of HPA axis hyperactivity by fluoxetine treatment involves reversal of glucocorticoid receptor (GR) phosphorylation via modulation of the GR negative regulator Fk506-binding protein 5 (Fkbp5) in the hypothalamic paraventricular nucleus (PVN). Fluoxetine treatment not only inhibited chronic stress-induced depression-like behaviors and HPA axis hyperactivity but also reversed Fkbp5 upregulation and GR phosphorylation changes in the PVN, while adeno-associated virus (AAV)-based Fkbp5 overexpression in the PVN eliminated the antidepressant effects of fluoxetine. These findings may expand our understanding of the pharmacological effects of fluoxetine, and further identify Fkbp5 as a possible target for novel antidepressants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineTacrolimus Binding ProteinsReceptors, GlucocorticoidParaventricular Hypothalamic NucleusStress, PsychologicalAnimalsMiceMalePhosphorylationMice, Inbred C57BLPituitary-Adrenal SystemHypothalamo-Hypophyseal SystemDepressionTacrolimus Binding Protein 5

Stichwörter der Autor:innen

Chronic restraint stressChronic social defeat stressChronic unpredictable mild stressDepressionFkbp5Fluoxetine

Substanzen

FluoxetineTacrolimus Binding ProteinsReceptors, GlucocorticoidTacrolimus Binding Protein 5

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China; Department of Clinical Nursing, School of Nursing and Rehabilitation, Nantong University, Nantong 226001, Jiangsu, Chin…
  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China; Department of Pharmacy, Rugao People's Hospital, Rugao 226500, Jiangsu, China.
  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China.
  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001, Jiangsu, China. Electronic address: jiangbo78099@ntu.edu.cn.
  • Department of Clinical Nursing, School of Nursing and Rehabilitation, Nantong University, Nantong 226001, Jiangsu, China. Electronic address: zhy1983@ntu.edu.cn.

Zitieren

APA

Zhu, B. L., Tang, J. Y., Chen, W. J., Qian, J. J., Zhang, F., Zhang, X. L., Chen, T. T., Jiang, B., & Zhao, H. Y. (2025). Fluoxetine treatment reverses chronic stress-induced promotion on Fk506-binding protein 5 expression and multiple effects on glucocorticoid receptor phosphorylation in the paraventricular nucleus of mice. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173916

Vancouver

Zhu BL, Tang JY, Chen WJ, Qian JJ, Zhang F, Zhang XL, et al. Fluoxetine treatment reverses chronic stress-induced promotion on Fk506-binding protein 5 expression and multiple effects on glucocorticoid receptor phosphorylation in the paraventricular nucleus of mice. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2024.173916

BibTeX
@article{Zhu2025,
  author = {Zhu, Bao-Lun and Tang, Jin-Yan and Chen, Wei-Jia and Qian, Jun-Jie and Zhang, Feng and Zhang, Xiao-Ling and Chen, Ting-Ting and Jiang, Bo and Zhao, He-Yan},
  title = {Fluoxetine treatment reverses chronic stress-induced promotion on Fk506-binding protein 5 expression and multiple effects on glucocorticoid receptor phosphorylation in the paraventricular nucleus of mice},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2024.173916}
}
Kostenlos starten →